Table 1. Characteristics of patients with end-stage cancer.
| Characteristics | Total patients (n=30) | SCC (n=14) | ADC (n=14) | Local-F (n=13) | Multi-M (n=25) |
|---|---|---|---|---|---|
| Age (years), median [range] | 57 [28–86] | 59 [47–86] | 54 [28–60] | 60 [47–86] | 57 [28–81] |
| Gender, n (%) | |||||
| Male | 15 (50.0) | 9 (64.3) | 5 (35.7) | 7 (53.8) | 12 (48.0) |
| Female | 15 (50.0) | 5 (35.7) | 9 (64.3) | 6 (46.2) | 13 (52.0) |
| Pathology, n (%) | |||||
| SCC | 14 (46.7) | 14 (100.0) | 0 (0.0) | 11 (84.6) | 9 (36.0) |
| ADC | 14 (46.7) | 0 (0.0) | 14 (100.0) | 1 (7.7) | 14 (56.0) |
| Others* | 2 (6.7) | 0 (0.0) | 0 (0.0) | 1 (7.7) | 2 (8.0) |
| Primary tumor, n (%) | |||||
| Head and neck cancer | 10 (33.3) | 9 (64.3) | 0 (0.0) | 6 (46.2) | 6 (24.0) |
| Gynecological cancer | 7 (23.3) | 2 (14.3) | 5 (35.7) | 3 (23.1) | 6 (24.0) |
| Digestive cancer | 13 (43.3) | 3 (21.4) | 9 (64.3) | 4 (30.8) | 13 (52.0) |
| Previous treatment | |||||
| Average number of surgeries, median (range) | 1.2 (0–7) | 1.4 (0–7) | 1.1 (0–2) | 1.5 (0–7) | 1.0 (0–3) |
| Average number of radiotherapy sessions, median (range) | 1.6 (0–6) | 2.3 (1–6) | 1.1 (0–4) | 2.2 (1–4) | 1.6 (0–6) |
| Average number of chemotherapy cycles, median (range) | 10.2 (0–60) | 5.7 (0–18) | 15.9 (5–60) | 8.9 (0–46) | 11.1 (1–60) |
| Course of disease (months), median (range) | 33.4 (6.6–181.7) | 22.3 (6.6–59.6) | 45.6 (8.3–181.7) | 29.5 (6.6–76.6) | 36.1 (7.0–181.7) |
| Local failure after multiline treatment, n (%) | 13 (43.3) | 11 (78.6) | 2 (14.3) | 13 (100.0) | 8 (25.0) |
| Tolerance to chemotherapy, n (%) | |||||
| No | 16 (53.3) | 10 (71.4) | 6 (42.9) | 8 (61.5) | 12 (48.0) |
| Yes | 14 (46.7) | 4 (28.6) | 8 (57.1) | 5 (38.5) | 13 (52.0) |
*, others included sarcoma and ACC. SCC, squamous cell cancer; ADC, adenocarcinoma; ACC, adenoid cystic carcinoma; Local-F, local failure; Multi-M, multiple metastases.